Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South America Sterilization Technologies Market

ID: MRFR/HC/47645-HCR
200 Pages
Nidhi Mandole
Last Updated: April 06, 2026

South America Sterilization Technologies Market Research Report By Technology (Heat Sterilization, Radiation Sterilization, Chemical Sterilization, Filtration Sterilization, Plasma Sterilization), By Method (Steam Sterilization, Dry Heat Sterilization, Ethylene Oxide Sterilization, Gamma Radiation Sterilization, Ultraviolet Sterilization), By End Use (Healthcare Facilities, Pharmaceuticals, Food Industry, Laboratories, Home Care), By Application (Medical Devices, Surgical Instruments, Pharmaceutical Products, Research and Development, Laboratory Equipment) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

South America Sterilization Technologies Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Application (USD Billion)
  49.     4.1.1 Medical
  50.     4.1.2 Pharmaceutical
  51.     4.1.3 Food Processing
  52.     4.1.4 Laboratory
  53.     4.1.5 Industrial
  54.   4.2 Healthcare, BY Technology Type (USD Billion)
  55.     4.2.1 Steam Sterilization
  56.     4.2.2 Ethylene Oxide Sterilization
  57.     4.2.3 Radiation Sterilization
  58.     4.2.4 Plasma Sterilization
  59.     4.2.5 Chemical Sterilization
  60.   4.3 Healthcare, BY End User (USD Billion)
  61.     4.3.1 Hospitals
  62.     4.3.2 Pharmacies
  63.     4.3.3 Research Institutions
  64.     4.3.4 Food Manufacturers
  65.     4.3.5 Laboratories
  66. 5 SECTION V: COMPETITIVE ANALYSIS
  67.   5.1 Competitive Landscape
  68.     5.1.1 Overview
  69.     5.1.2 Competitive Analysis
  70.     5.1.3 Market share Analysis
  71.     5.1.4 Major Growth Strategy in the Healthcare
  72.     5.1.5 Competitive Benchmarking
  73.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  74.     5.1.7 Key developments and growth strategies
  75.       5.1.7.1 New Product Launch/Service Deployment
  76.       5.1.7.2 Merger & Acquisitions
  77.       5.1.7.3 Joint Ventures
  78.     5.1.8 Major Players Financial Matrix
  79.       5.1.8.1 Sales and Operating Income
  80.       5.1.8.2 Major Players R&D Expenditure. 2023
  81.   5.2 Company Profiles
  82.     5.2.1 Steris Corporation (US)
  83.       5.2.1.1 Financial Overview
  84.       5.2.1.2 Products Offered
  85.       5.2.1.3 Key Developments
  86.       5.2.1.4 SWOT Analysis
  87.       5.2.1.5 Key Strategies
  88.     5.2.2 Getinge AB (SE)
  89.       5.2.2.1 Financial Overview
  90.       5.2.2.2 Products Offered
  91.       5.2.2.3 Key Developments
  92.       5.2.2.4 SWOT Analysis
  93.       5.2.2.5 Key Strategies
  94.     5.2.3 Ecolab Inc. (US)
  95.       5.2.3.1 Financial Overview
  96.       5.2.3.2 Products Offered
  97.       5.2.3.3 Key Developments
  98.       5.2.3.4 SWOT Analysis
  99.       5.2.3.5 Key Strategies
  100.     5.2.4 Belimed AG (CH)
  101.       5.2.4.1 Financial Overview
  102.       5.2.4.2 Products Offered
  103.       5.2.4.3 Key Developments
  104.       5.2.4.4 SWOT Analysis
  105.       5.2.4.5 Key Strategies
  106.     5.2.5 Advanced Sterilization Products (US)
  107.       5.2.5.1 Financial Overview
  108.       5.2.5.2 Products Offered
  109.       5.2.5.3 Key Developments
  110.       5.2.5.4 SWOT Analysis
  111.       5.2.5.5 Key Strategies
  112.     5.2.6 3M Company (US)
  113.       5.2.6.1 Financial Overview
  114.       5.2.6.2 Products Offered
  115.       5.2.6.3 Key Developments
  116.       5.2.6.4 SWOT Analysis
  117.       5.2.6.5 Key Strategies
  118.     5.2.7 Sotera Health Company (US)
  119.       5.2.7.1 Financial Overview
  120.       5.2.7.2 Products Offered
  121.       5.2.7.3 Key Developments
  122.       5.2.7.4 SWOT Analysis
  123.       5.2.7.5 Key Strategies
  124.     5.2.8 MediClean (BR)
  125.       5.2.8.1 Financial Overview
  126.       5.2.8.2 Products Offered
  127.       5.2.8.3 Key Developments
  128.       5.2.8.4 SWOT Analysis
  129.       5.2.8.5 Key Strategies
  130.   5.3 Appendix
  131.     5.3.1 References
  132.     5.3.2 Related Reports
  133. 6 LIST OF FIGURES
  134.   6.1 MARKET SYNOPSIS
  135.   6.2 SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
  136.   6.3 SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY TYPE
  137.   6.4 SOUTH AMERICA MARKET ANALYSIS BY END USER
  138.   6.5 KEY BUYING CRITERIA OF HEALTHCARE
  139.   6.6 RESEARCH PROCESS OF MRFR
  140.   6.7 DRO ANALYSIS OF HEALTHCARE
  141.   6.8 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  142.   6.9 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  143.   6.10 SUPPLY / VALUE CHAIN: HEALTHCARE
  144.   6.11 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  145.   6.12 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
  146.   6.13 HEALTHCARE, BY TECHNOLOGY TYPE, 2024 (% SHARE)
  147.   6.14 HEALTHCARE, BY TECHNOLOGY TYPE, 2024 TO 2035 (USD Billion)
  148.   6.15 HEALTHCARE, BY END USER, 2024 (% SHARE)
  149.   6.16 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
  150.   6.17 BENCHMARKING OF MAJOR COMPETITORS
  151. 7 LIST OF TABLES
  152.   7.1 LIST OF ASSUMPTIONS
  153.     7.1.1
  154.   7.2 South America MARKET SIZE ESTIMATES; FORECAST
  155.     7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
  156.     7.2.2 BY TECHNOLOGY TYPE, 2026-2035 (USD Billion)
  157.     7.2.3 BY END USER, 2026-2035 (USD Billion)
  158.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  159.     7.3.1
  160.   7.4 ACQUISITION/PARTNERSHIP
  161.     7.4.1

South America Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2022-2035)

  • Medical
  • Pharmaceutical
  • Food Processing
  • Laboratory
  • Industrial

Healthcare By Technology Type (USD Billion, 2022-2035)

  • Steam Sterilization
  • Ethylene Oxide Sterilization
  • Radiation Sterilization
  • Plasma Sterilization
  • Chemical Sterilization

Healthcare By End User (USD Billion, 2022-2035)

  • Hospitals
  • Pharmacies
  • Research Institutions
  • Food Manufacturers
  • Laboratories

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions